PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 29277827
OWN - NLM
STAT- MEDLINE
DCOM- 20180104
LR  - 20180104
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 38
IP  - 1
DP  - 2018 Jan
TI  - The Efficacy of Wide Resection for Musculoskeletal Metastatic Lesions of Renal
      Cell Carcinoma.
PG  - 577-582
AB  - BACKGROUND/AIM: This study evaluated the outcome of wide resection for metastatic
      renal cell carcinoma (RCC) to the bone or soft tissue. PATIENTS AND METHODS:
      Thirty patients who underwent surgery for bone or soft tissue metastatic lesions 
      of RCC were retrospectively evaluated. The surgical procedures were wide
      resection in 14 patients (group 1) and intralesional resection in 16 (group 2).
      RESULTS: The 3-, 5-, 10-, and 15-year overall survival (OS) was 76%, 48%, 35%,
      and 23%, respectively, and OS was significantly favorable in group 1. In
      addition, recurrence-free survival rate was significantly higher in group 1. In
      the multivariate analysis, intralesional resection was an independent risk factor
      for poor prognosis. There was no significant difference in surgical time, though 
      intraoperative hemorrhage was significantly larger in group 2. CONCLUSION: The
      wide resection of bone and soft tissue metastatic lesions of RCC is a favorable
      option for controlling local metastasis and improving prognosis.
CI  - Copyright(c) 2018, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Higuchi, Takashi
AU  - Higuchi T
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Yamamoto, Norio
AU  - Yamamoto N
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Hayashi, Katsuhiro
AU  - Hayashi K
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Takeuchi, Akihiko
AU  - Takeuchi A
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Kato, Satoshi
AU  - Kato S
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Miwa, Shinji
AU  - Miwa S
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Abe, Kensaku
AU  - Abe K
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Taniguchi, Yuta
AU  - Taniguchi Y
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Aiba, Hisaki
AU  - Aiba H
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan.
FAU - Tsuchiya, Hiroyuki
AU  - Tsuchiya H
AD  - Department of Orthopaedic Surgery, Graduate School of Medical Science, Kanazawa
      University, Kanazawa, Japan [email protected]
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Bone Neoplasms/mortality/secondary/*surgery
MH  - Carcinoma, Renal Cell/*pathology
MH  - Female
MH  - Humans
MH  - Kidney Neoplasms/*pathology
MH  - Lung Neoplasms/mortality/secondary/*surgery
MH  - Male
MH  - *Metastasectomy
MH  - Middle Aged
MH  - Prognosis
MH  - Retrospective Studies
MH  - Risk Factors
MH  - Soft Tissue Neoplasms/mortality/secondary/*surgery
OTO - NOTNLM
OT  - *Renal cell carcinoma
OT  - *metastasectomy
OT  - *musculoskeletal metastasis
OT  - *overall survival
OT  - *wide resection
EDAT- 2017/12/27 06:00
MHDA- 2018/01/05 06:00
CRDT- 2017/12/27 06:00
PHST- 2017/10/05 00:00 [received]
PHST- 2017/10/22 00:00 [revised]
PHST- 2017/10/23 00:00 [accepted]
PHST- 2017/12/27 06:00 [entrez]
PHST- 2017/12/27 06:00 [pubmed]
PHST- 2018/01/05 06:00 [medline]
AID - 38/1/577 [pii]
AID - 10.21873/anticanres.12262 [doi]
PST - ppublish
SO  - Anticancer Res. 2018 Jan;38(1):577-582. doi: 10.21873/anticanres.12262.